2020
DOI: 10.3233/jrs-200002
|View full text |Cite
|
Sign up to set email alerts
|

Patient safety issues associated with the use of compounded medicines as alternatives to approved pharmaceutical products in Europe and how best practice can improve outcomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 29 publications
0
2
0
1
Order By: Relevance
“…It must be considered that its teaching and study enable the development of key transversal competencies to achieve sustainable development goals. On the other hand, it allows work on the context, reflection, and action from critical positions, establishing interrelationships with social, economic, environmental, local, and global problems from the perspective of the health and well-being of people based on the intangible heritage of the communities themselves [9][10][11][12][13][14].…”
Section: Introductionmentioning
confidence: 99%
“…It must be considered that its teaching and study enable the development of key transversal competencies to achieve sustainable development goals. On the other hand, it allows work on the context, reflection, and action from critical positions, establishing interrelationships with social, economic, environmental, local, and global problems from the perspective of the health and well-being of people based on the intangible heritage of the communities themselves [9][10][11][12][13][14].…”
Section: Introductionmentioning
confidence: 99%
“…Compounded formulations prepared at the pharmacy or the patient's home are not in keeping with pharmaceutical manufacturing standards, and have the potential to cause patient harm. 4,5 A recent study showed that only 47% and 28% of product monographs of newly approved medications in Canada have pediatric-specific information and indications, respectively. 6 Another Canadian study at a tertiary pediatric hospital showed that 48% of frequently compounded medications were commercially available as childfriendly formulations in the United States or European Union.…”
mentioning
confidence: 99%
“…Pour les jeunes enfants, on doit souvent modifier la préparation commerciale (souvent un comprimé destiné aux adultes) avant de l’administrer, une pratique nommée préparation magistrale. Ces préparations, réalisées à la pharmacie ou à domicile, ne sont pas en accord avec les normes de fabrication pharmaceutiques et peuvent potentiellement être préjudiciables pour le patient 4 , 5 . Une étude récente a démontré que seulement 47 % et 28 % des monographies de produits de médicaments nouvellement approuvés au Canada comprenaient respectivement des renseignements et des indications, spécifiques à la clientèle pédiatrique 6 .…”
unclassified